Pharma Journalist - Page 828 of 829 -

5th Genome Editing Therapeutics Summit is only 3 weeks away!

Datopotamab Deruxtecan BLA Submitted for Accelerated Approval in the U.S. for Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Nippon Shinyaku and Atsena Therapeutics enter into an Exclusive Strategic Collaboration for ATSN-101 in the U.S. and Japan

Oracle Health Sciences to Provide Clinical E-Monitoring Solution to Bayer HealthCare

DNAtrix’s Oncolytic Immunotherapy, DNX-2401, Awarded EU Orphan Medicine Designation for Treating Malignant Brain Tumors

Panacea Pharmaceuticals selects Goodwin to develop anti-cancer monoclonal antibody

Genomics England selects QIAGEN hereditary and rare disease solution

Ono Pharmaceutical expands adoption of Medidata Clinical Cloud platform

Oracle Powers Precision Medicine Delivery with New Solution Connecting Research, Pathology and Clinical Care

Pathcore Selected by National Cancer Institute to Enable Cancer Informatics Development

Boehringer Ingelheim Selects Medidata Clinical Cloud to Accelerate Innovation in Drug Development

XL-protein & Easton sign license agreement to develop biopharmaceuticals using PASylation technology

PAREXEL Launches Impact Express Clinical Trial Management System